Over-Expression of CD200 In Acute Myeloid Leukemia Mediates the Expansion of Regulatory T-Lymphocytes and Directly Inhibits Natural Killer Cell Tumor Immunity

生物 髓样 髓系白血病 免疫学 FOXP3型 白细胞介素2受体 癌症研究 免疫系统 白血病 T细胞
作者
Steven Coles,Stephen Man,Robert Kerrin Hills,Edward Chung Yern Wang,Alan Kenneth Burnett,Richard Lawrence Darley,Alex Tonks
出处
期刊:Blood [Elsevier BV]
卷期号:116 (21): 491-491 被引量:3
标识
DOI:10.1182/blood.v116.21.491.491
摘要

Abstract Abstract 491 CD200 is a type-1 transmembrane glycoprotein which suppresses inflammatory and autoimmune responses by signalling through its cognate transmembrane receptor homologue (CD200R). Normally, CD200 expression is restricted to immune privileged sites where it enhances immune tolerance through mechanisms that include modulating the expansion of FOXP3+ regulatory T-lymphocytes (T-regs) and suppressing macrophage cytolytic activity. Furthermore, leukocyte associated CD200 has been reported to suppress Natural Killer (NK) cell activity in vivo. Pathologically, we have previously shown that CD200 over-expression on leukemic blasts in around 50% of acute myeloid leukemia (AML) patients is significantly associated with a poor overall survival (Tonks et al, Leukemia, 2007). Given the existing evidence that T-reg frequency and NK cell function influence blast clearance and long-term survival in AML, we investigated the possibility that CD200 expression in AML may be directly suppressing anti-tumor immunity in this disease. Here we present evidence that CD200+ AML can suppress host anti-tumor responses by augmenting the frequency of AML patient T-regs and by direct inhibition of NK cell anti-tumor activity. We also show that targeting the interaction between CD200 and its receptor might provide a new strategy for the treatment of AML. Bone marrow aspirates from 91 diagnostic AML patients were analysed by multiparameter flow cytometry for blast CD200 protein expression. We found that the level of blast CD200 expression directly correlated with an increased frequency of T-regs (CD4+CD25++FoxP3+; R=0.78, p=0.0008). Measuring 3H-thymidine incorporation, we show that T-regs isolated from AML patients by MACS® separation inhibited T-cell proliferation (induced by CD3 and CD28 stimulation) at ratios <0.1%, thus confirming that patients T-regs were functional. In contrast to T-regs, NK cell frequency (CD45+CD19−CD3−CD56+) did not correlate with the level of AML blast CD200 expression (R=0.15, p=0.851), however, NK cell subpopulation bivariate analysis using CD56 and CD16 demonstrated that the CD56dimCD16+ (the principle active NK population) was significantly reduced by over 50% in CD200+ AML patients (36±5% compared to 15±5%, p=0.009). Furthermore, CD200 expression on target cells appeared to have a direct effect on the cytotoxic activity of NK cells; co-culture of NK cells with CD200+ targets resulted in decreased CD107a expression (a marker for cytolytic granules) in NK cells (23±4% vs 12±5%, p=0.038) and decreased apoptosis of the target cells (19±1% vs 10±1%, p=0.041). Since CD200R was detected on NK cells in AML patients, it was likely that CD200 was having a direct effect on suppression of NK cytotoxicity. This was supported by the significant recovery of NK cytolytic activity against CD200+ blasts in the presence of a CD200 blocking antibody (5±1% vs 11±2% CD107a+ NK cells, p=0.046) whereas there was no change seen with CD200− blasts (19±4% vs 19±3%). In conclusion, these findings suggest that CD200 expression on leukemic blasts plays an influential role in suppressing anti-tumor immunity in AML patients through modulating the expansion of functionally suppressive T-regs and directly suppressing NK cell cytolytic activity. In this study blocking CD200 interaction with its receptor was able to recover a significant proportion of patient NK activity, making CD200 a potential therapeutic target for CD200+ AML. Disclosures: No relevant conflicts of interest to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张牧之完成签到 ,获得积分10
刚刚
冷冷暴力完成签到,获得积分10
2秒前
YYY完成签到,获得积分10
2秒前
2秒前
gujian完成签到 ,获得积分10
5秒前
帅气的秘密完成签到 ,获得积分10
6秒前
自然函发布了新的文献求助10
10秒前
冰冰双双完成签到,获得积分10
10秒前
开心夏旋完成签到 ,获得积分0
12秒前
我要读博士完成签到 ,获得积分10
15秒前
活泼的大船完成签到,获得积分10
15秒前
AFF完成签到,获得积分10
16秒前
17秒前
无私小小完成签到,获得积分10
18秒前
随心所欲完成签到 ,获得积分10
19秒前
润润轩轩完成签到 ,获得积分10
20秒前
CodeCraft应助大橙子采纳,获得10
20秒前
ZR完成签到,获得积分10
21秒前
magictoo完成签到,获得积分10
21秒前
陈昊发布了新的文献求助10
22秒前
zhangliangfu完成签到 ,获得积分10
22秒前
金石为开完成签到,获得积分10
22秒前
王QQ完成签到 ,获得积分10
24秒前
唐唐完成签到 ,获得积分10
28秒前
最棒哒完成签到 ,获得积分10
28秒前
鸣鸣完成签到,获得积分10
29秒前
123321完成签到 ,获得积分10
30秒前
卓若之完成签到 ,获得积分10
31秒前
苯二氮卓完成签到,获得积分10
32秒前
温暖完成签到 ,获得积分10
34秒前
mojomars完成签到,获得积分10
34秒前
时尚雨兰完成签到,获得积分0
35秒前
一叶知秋完成签到,获得积分10
37秒前
叶123完成签到,获得积分10
38秒前
量子星尘发布了新的文献求助10
39秒前
Minicoper发布了新的文献求助10
39秒前
背书强完成签到 ,获得积分10
40秒前
淡然以柳完成签到 ,获得积分10
42秒前
dolabmu完成签到 ,获得积分10
45秒前
崔崔完成签到 ,获得积分10
49秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022